“There are no words to explain how much suffering this has caused our little girl and how much despair and helplessness we as her family have endured,” stated Devon Addonizio of New York, New York. …
Read the full story »The New York Times reports that while the pharmaceutical industry “has developed thousands of medicines that have saved millions of lives, it has also used its marketing muscle to successfully peddle expensive pills that are no more effective than older drugs sold at a fraction of the cost.”
A new Food and Drug Administration study has identified lead in all 20 red lipsticks it tested (from 10 different brands), and at concentrations up to four-times higher than those found in independent testing.
Lieff Cabraser has posted several important silicone gel breast implant-related updates this year with regard to both the Dow Settlement and the Revised Settlement Program.
As reported by CBS News, one of the Toyota’s former lawyers has filed a federal racketeering suit against the Japanese automaker.
Consumer Attorneys of California president Christine D. Spagnoli today lauded New Chrysler for accepting responsibility for vehicles produced by Chrysler prior to its bankruptcy. “On behalf of all consumers, we are heartened that Chrysler understands the need to accept responsibility for defective products.”
A recent warning letter to pharmaceutical company Allergan Inc. by the U.S. Food and Drug Administration could be a prelude to suits by states, according to legal experts. At least one noted that the tone and wording of the FDA’s letter was the harshest in recent memory.
Police departments across the country are reporting significant dangers to boaters and other water enthusiasts from widespread ongoing incidents of “drunken boating.” A roundup of boating accident news from just the last week reveals numerous serious injuries and at least one death directly attributed to people operating their boats while intoxicated.
The European Medicines Agency (EMEA) posted a public statement in which it announced the timeline for the withdrawl of the marketing authorization for the psoriasis drug Raptiva (efalizumab).
Nearly 50 Zimmer patients from more than 25 states have filed lawsuits seeking compensation for their physical injuries, cost of replacement surgery and other financial difficulties as a result of the failure of their implant.
Lawsuits have been filed against Bayer, the manufacturer of Yaz and Yasmin, alleging the company failed to adequately warn patients and physicians of the increased risk of serious adverse effects from Yasmin and Yaz, while touting the birth control advantages of the drugs in television advertisements.
As was reported recently throughout the media and highlighted in the entry “FDA Head of Medical Devices Resigns” on our companion blog on the Medtronic Heart Lead recall, Dr. Daniel Schultz resigned from his post as the head of the FDA’s medical devices division.
Two years ago, Michael Mulvihill of Bettendorf, Iowa, was driving when he saw a blue light flash before his eyes. His heart defibrillator was malfunctioning and sending electrical shocks throughout his body.